Orphazyme A/S ADR (ORPH) Social Stream
Orphazyme A (ORPH) Price Targets From Analysts
Use the tables below to see what analysts covering Orphazyme A think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2022-02-23 | 3 | $1 | $1 | $1 | $0.87 | 14.94% |
2022-03-11 | 2 | $1 | $1 | $1 | $0.87 | 14.94% |
Over the past 164 days, ORPH's average upside potential has been -32.76%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2021-09-28 | 3 | 1 | 1 | 1 | 4.210 | -76.25% |
2022-02-23 | 3 | 1 | 1 | 1 | 2.020 | -50.5% |
2022-02-23 | 2 | 1 | 1 | 1 | 2.020 | -50.5% |
2022-03-11 | 2 | 1 | 1 | 1 | 0.684 | 46.2% |
ORPH Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
4.5 | 0 | 0 | 0 | 1 | 1 | 2 |
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORPH as an investment opportunity.
- Orphazyme A's variance in analysts' estimates is lower than nearly 100% of all US stocks.
- In terms of how Orphazyme A fares relative to all US stocks, note that its average analyst price target is higher than 0.1% of that group.
- Orphazyme A's upside potential (average analyst target price relative to current price) is greater than 16.7% of Pharmaceutical Products stocks.
- Orphazyme A's number of analysts covering the stock is greater than 16.99% of Healthcare stocks.
Stocks similar to Orphazyme A in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ORMP, ORIC, and OPTN.
Make investment decisions regarding ORPH using the data that counts. Try POWR Ratings for free.